Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Articles published by Athersys, Inc.

Athersys Announces That Its Partner, HEALIOS K.K., Reported Topline Data From the TREASURE Multistem Ischemic Stroke Study
From Athersys, Inc.
Via Business Wire
Tickers ATHX
Athersys to Participate in the H.C. Wainwright Global Investment Conference
From Athersys, Inc.
Via Business Wire
Tickers ATHX
Athersys Reports First Quarter 2022 Results
From Athersys, Inc.
Via Business Wire
Tickers ATHX
Athersys to Announce First Quarter Financial Results on May 6
From Athersys, Inc.
Via Business Wire
Tickers ATHX
Athersys Reports That Its Partner, HEALIOS K.K., Provides Updates on MultiStem® Clinical Programs in Japan
From Athersys, Inc.
Via Business Wire
Tickers ATHX
Athersys to Participate in Two Upcoming Investor Conferences
From Athersys, Inc.
Via Business Wire
Tickers ATHX
Athersys Reports Fourth Quarter and Full Year 2021 Financial Results and Business Highlights
From Athersys, Inc.
Via Business Wire
Tickers ATHX
Athersys Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
From Athersys, Inc.
Via Business Wire
Tickers ATHX
Athersys to Host Year-End 2021 Financial Results Call
From Athersys, Inc.
Via Business Wire
Tickers ATHX
Athersys to Host a Virtual Presentation on Its MultiStem® Programs
From Athersys, Inc.
Via Business Wire
Tickers ATHX
Athersys Appoints Experienced Commercial Leader, Daniel A. Camardo, to Chief Executive Officer
From Athersys, Inc.
Via Business Wire
Tickers ATHX
Athersys Reports Third Quarter 2021 Results and Provides Corporate Update
From Athersys, Inc.
Via Business Wire
Tickers ATHX
Report of Placebo-Controlled Clinical Trial Evaluating MultiStem® Cell Therapy for Acute Respiratory Distress Syndrome Published in Intensive Care Medicine
From Athersys, Inc.
Via Business Wire
Tickers ATHX
Athersys to Host Third Quarter Financial Results Call
From Athersys, Inc.
Via Business Wire
Tickers ATHX
Athersys to Present at 2021 Cell & Gene Meeting on the Mesa Hybrid Conference
From Athersys, Inc.
Via Business Wire
Tickers ATHX
Athersys Partner HEALIOS K.K. Completes Enrollment in the TREASURE Study of MultiStem Treatment for Ischemic Stroke
From Athersys, Inc.
Via Business Wire
Tickers ATHX
Athersys Reports Second Quarter 2021 Results
From Athersys, Inc.
Via Business Wire
Tickers ATHX
Athersys Partner HEALIOS K.K. Announces Positive Topline Results of MultiStem for Acute Respiratory Distress Syndrome in the ONE-BRIDGE Study
From Athersys, Inc.
Via Business Wire
Tickers ATHX
Athersys to Host Second Quarter Financial Results Call
From Athersys, Inc.
Via Business Wire
Tickers ATHX
New Publication Provides Further Clarity of MultiStem's Mechanism of Action on Modulating the Inflammatory Response in Critical Care Indications
From Athersys, Inc.
Via Business Wire
Tickers ATHX
Athersys Reports First Quarter 2021 Results
From Athersys, Inc.
Via Business Wire
Tickers ATHX
Athersys to Host First Quarter Financial Results Call
From Athersys, Inc.
Via Business Wire
Tickers ATHX
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.